Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum β-lactamases or plasmid-mediated AmpC-type β-lactamases

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 3, 2008, Pages 343-345

  Conejo, M Carmen ^a   Hernández, J Ramón ^a   Pascual, Álvaro ^a,b  

^a School of Medicine   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Extended spectrum lactamase; Klebsiella pneumoniae; Porin; Tigecycline

Indexed keywords

BETA LACTAMASE AMPC; CEFEPIME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PORIN; TIGECYCLINE;

AGAR GEL ELECTROPHORESIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BROTH DILUTION; CONTROL GROUP; DNA SEQUENCE; DRUG SENSITIVITY; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PLASMIDS; PORINS;

EID: 45349093221     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.01.023     Document Type: Article

References (12)

1. Cao V.T.B., Arlet G., Ericsson B., Tammelin A., Courvalin P., and Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46 (2000) 895-900
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Document M100-S17. Seventeenth Informational Supplement (2007), Clinical and Laboratory Standards Institute, Wayne, PA
3. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., and Pascual A. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49 (2005) 2122-2125
4. Hernández-Allés S., Conejo M.D.C., Pascual A., Tomás J.M., Benedí V.J., and Martínez-Martínez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46 (2000) 273-277
5. Hope R., Warner M., Potz N.A.C., Fagan E.J., James D., and Livermore D.M. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from South-East England. J. Antimicrob. Chemother. 58 (2006) 1312-1314
6. Kang C., Pai H., Kim S., Kim H., Kim E., Oh M., and Choe K. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase. J. Antimicrob. Chemother. 54 (2004) 1130-1133
7. Martínez-Martínez L., Pascual A., Hernández-Allés S., Alvarez-Díaz D., Suárez A.I., Tran J., Benedi V.J., and Jacoby G.A. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43 (1999) 1669-1673
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Document M7-A6 (2003), National Committee for Clinical Laboratory Standards, Wayne, PA
9. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control. 34 Suppl 1 (2006) S20-S28
10. Pérez-Pérez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40 (2002) 2153-2162
11. Woodford N., Hill R.L.R., and Livermore D.M. In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp. J. Antimicrob. Chemother. 59 (2007) 582-583
12. Wyeth Pharmaceuticals. Tygacil Product Insert (2005), Wyeth Pharmaceuticals, Philadelphia, PA. http://www.tygacil.com [Online.] http://www.tygacil.com